A recent study indicates that people who discontinue new weight-loss injections like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who stop conventional lifestyle plans.
Published data in a major health publication shows that while overweight people can lose a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs must be cognizant of the potential of quick rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.
That rate of recovery means a reversion to starting mass within about a year and a half.
Comparing Therapies
The analysis, which looked at 37 of trials involving over 9,000 of patients, contrasted the outcomes of these new drugs with other pills.
Researchers point out that people who lose weight through lifestyle changes alone usually experience a slower weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Experts believe the way of the injections accounts for the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts say that, considering the likelihood of relapse, the therapy is often long-term.
This opinion is supported by pharmaceutical companies, who state that the findings "underscore the long-term character of obesity," comparing it to managing diseases like hypertension.
Patient Experiences
Individuals who have stopped the jabs explain a intense return of cravings.
"It felt as if something that goes on and you're instantly starving," recalled a patient.
The struggle is worsened if individuals have not adopted permanent lifestyle or habit changes during therapy.
Widespread Interest
Figures show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Adoption is more common among women than males.
- The middle-aged age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a standalone cure and maintained weight loss likely depends on integrated lifestyle management.
